Patent ductus arteriosus in preterm neonates

Indian Journal of Pediatrics

Volumn 75, Issue 3, 2008, Pages 277-280

  Agarwal, Ramesh ^a   Deorari, Ashok K ^a   Paul, Vinod K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Ibuprofen; Indomethacin; Patent ductus arteriosus; Preterm

Indexed keywords

ENDOTHELIN; FUROSEMIDE; IBUPROFEN; INDOMETACIN; PROSTACYCLIN; PROSTAGLANDIN E2;

AORTOPULMONARY SEPTAL DEFECT; ARTERIOVENOUS FISTULA; BLEEDING; CLINICAL FEATURE; CLINICAL PROTOCOL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DETERIORATION; DIFFERENTIAL DIAGNOSIS; DRUG ANTAGONISM; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DUCTUS ARTERIOSUS OBLITERATION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FLUID INTAKE; FLUID RESTRICTION; HEART LEFT RIGHT SHUNT; HEMODYNAMICS; HUMAN; LIGATION; METABOLIC ACIDOSIS; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEPHROTOXICITY; NEUROTOXICITY; NEWBORN; OXYGEN TENSION; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PROPHYLAXIS; RETREATMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; THORAX RADIOGRAPHY;

CARDIOVASCULAR AGENTS; DIAGNOSIS, DIFFERENTIAL; DUCTUS ARTERIOSUS, PATENT; FLUID THERAPY; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; RISK FACTORS;

EID: 44049102699     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-008-0059-9     Document Type: Conference Paper

References (16)

1. th ed. 2008; 388-435.
2. rd ed. Churchill Livingstone, 1999; 687-689.
3. th ed. WB Saunders; 2005; 816-826.
4. th ed. 1997; 1155-1157.
5. Clyman RI. Treatment of premature neonates with patent ductus arteriosus: analysis of four treatment strategies. J Pediatr 1996; 128: 601-607.
6. Foulie WP. Prophylactic Indomethacin - systematic review and meta-analysis. Arch Dis Child 1996; 74: F81-F87.
7. De Carolis MP, Romagnoli C, Polimeni V, Piersigilli F, Zecca E, Pappacci P et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur J Pediatr 2000; 159: 364-368.
8. Bose CL, Laughan MM. Patent ductus arteriosus: Lack of evidence for common treatments. Arch Dis Child Fetal Neonatal 2007; 92: F498-F502.
9. Vanhaesebrouck S, Zonnenberg I, Vandervoot P et al. Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed 2007; 92: F244-F247.
10. Brion LP, Campbell DE. Furosemide in indomethacin treated infants-systematic review and meta-analysis. Pediatr Nephrol 1999; 13: 212-218.
11. Fajardo CA, Whyte RK, Stele BT. Effect of dopamine on failure of indomethacin to close patent ductus arteriosus. J Pediatr 1992; 121: 771-775.
12. Tammela O, Ojala R, Livainen T, Lautamatti V, Pokela ML, Janas M et al. Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants. J Pediatr 1999; 134: 552-557.
13. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000; 343: 674-681.
14. Burke RP, Jacobs JP, Cheng W, Trento A, Fontana GP. Video-assisted thoracoscopic surgery for patent ductus arteriosus in low birth weight neonates and infants. Pediatrics 1999; 104: 227-230.
15. Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2000; 2: CD000503.
16. Mc Namara, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal 2007; 92: F425-F427.